Fat-loss drug Mounjaro now India's No. 2 pharma brand

NEW DELHI: Soaring request for weight-loss therapies has brought Eli Lilly's Mounjaro wrong striking region of Indian pharma market's agelong lasting marketplace person GlaxoSmithKline's Augmentin, an antibiotic.

During September, Mounjaro recorded income of Rs 80 crore, becoming the second-largest marque successful the pharma retail market, latest information culled by TOI from marketplace probe steadfast Pharmatrac showed. As against this, Augmentin generated income of Rs 85 crore during the month. Typically, top-selling medicines successful the pharmaceutical marketplace are either Augmentin oregon anti-diabetic therapy, Mixtard, which generates astir Rs 75-80 crore successful monthly sales.

Launched successful March this year, Mounjaro generated a cumulative gross of Rs 233 crore by September.

Augmentin portion worth little than Mounjaro’sIndustry experts said the instauration of Mounjaro successful a pre-filled device, KwikPen, successful August has boosted sales.A cardinal crushed for the income is the higher portion worth of the cause adjacent though the volumes are lower. Average monthly outgo of Mounjaro for a diligent starts from Rs 14,000 and goes up to Rs 27,000, depending connected the prescription.

In contrast, a portion of 10 tablets of Augmentin 625 Duo costs nether Rs 200.Sales of Mounjaro's rival, Wegovy, marketed by Novo Nordisk, have, however, plateaued astir Rs 9 crore. The institution is said to beryllium cutting income jobs, amid rising contention successful the segment. Overall, the organised pharma retail marketplace mopped up full income of implicit Rs 20,000 crore successful September, a maturation of 7.3%, the latest information added. Market enlargement was driven by caller merchandise introductions and terms hikes, with each therapies reporting higher value.Augmentin and Glycomet GP proceed to clasp their enactment presumption astatine the MAT (moving yearly total) level. Sept was besides the period erstwhile the GST simplification from 18% to 5% was rolled out. A flimsy disturbance was seen successful the organisation transmission during the month, though determination was nary disruption astatine the retail level, experts said.